Clotting disorders

DOAC neutraliser prevents misleading coag results

Evidence is building for the utility of DOAC Stop to neutralise the effects of the direct-acting oral anticoagulants (DOACs) on laboratory tests such as prothrombin time (PT) and factor VIII assays. A UK study of plasma samples from 40 DOAC anticoagulated patients and 20 patients who were not anticoagulated showed that the Australian-made product DOAC ...

Already a member?

Enter your email to keep reading.